Professor, Neurology, Washington University School of Medicine
Neurology
Dr. Brad Racette, MD
|
|
Give Review
Doctor Brad Racette, MD is an expert in the field of Neurology. He attended Northwestern University Feinberg School of Medicine. Northwestern University Feinberg School of Medicine has a rank of 19 in research and a 29 in primary care He over the years received 1 awards: "Regional Top Doctor". Brad Racette is a published doctor. He published 81 publications, including: 'Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's disease.' He is registered with Medicare.
Publications
- Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
- Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders.
- Neurological outcomes associated with low-level manganese exposure in an inception cohort of asymptomatic welding trainees.
- Formulations of hormone therapy and risk of Parkinson's Disease.
- 0239  Inducible nitric oxide synthase gene methylation and parkinsonism in manganese-exposed welders0239  Inducible nitric oxide synthase gene methylation and parkinso...
- A rare sequence variant in intron 1 of THAP1 is associated with primary Dystonia.
- Blood manganese as an exposure biomarker: state of the evidence.
- Relative mortality in u.s. Medicare beneficiaries with Parkinson Disease and hip and pelvic fractures.
- Disparities in deep brain stimulation surgery among insured elders with Parkinson Disease.
- Quantitative neuropathology associated with chronic manganese exposure in South African mine workers.
- Variables associated with return to sport following anterior cruciate ligament reconstruction: a systematic review.
- Screening for early detection of parkinsonism using a self-administered questionnaire: A cross-sectional epidemiologic study.
- Parkinson Disease is not associated with C9ORF72 repeat expansions.
- Epidemiology and neuropsychiatric manifestations of Young Onset Parkinson's Disease in the United States.
- Pathologic accumulation of α-synuclein and Aβ in Parkinson Disease patients with dementia.
- Association of variations in monoamine oxidases A and B with Parkinson's Disease subgroups.
- Preventing contractures [correction of contractions] in neuroleptic malignant syndrome and Dystonia.
- Mutation, sequence analysis, and association studies of alpha-synuclein in Parkinson's Disease.
- Levodopa responsive parkinsonism in an adult with Huntington''s Disease.
- Preoperative treatment with botulinum toxin to facilitate cervical fusion in dystonic cerebral Palsy. Report of two cases.
- Dystonia in a patient with ring chromosome 21.
- A haplotype at the PARK3 locus influences onset age for Parkinson''s Disease: the GenePD study.
- Botulinum toxin B reduces sialorrhea in parkinsonism.
- Ptosis as a remote effect of therapeutic botulinum toxin B injection.
- Clinical features and comorbidity of mood fluctuations in Parkinson's Disease.
- Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024).
- Ipsilateral thalamic stimulation after thalamotomy for Essential tremor. A case report.
- A multi-incident, Old-Order Amish family with PD.
- Parkinson's Disease and apolipoprotein E: possible association with dementia but not age at onset.
- Late-onset neurodegeneration with brain iron accumulation type 1: expanding the clinical spectrum.
- Thalamic stimulation for primary writing Tremor.
- Chorea and jaw-opening Dystonia as a manifestation of NeuroBehcet's syndrome.
- Efficacy and safety of a new bulk toxin of botulinum toxin in cervical Dystonia: a blinded evaluation.
- Convergence insufficiency in idiopathic Parkinson''s Disease responsive to levodopa.
- Evaluation of a screening questionnaire for genetic studies of Parkinson's Disease.
- Pregnancy in multiple system atrophy: a case report.
- Reduced uptake of [18F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
- Neurologist care in Parkinson Disease: a utilization, outcomes, and survival study.
- Effects of parkinsonism on health status in welding exposed workers.
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.
- Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.
- Reduced uptake of [¹â¸F]FDOPA PET in asymptomatic welders with occupational manganese exposure.
- The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary Dystonia.
- Metal emissions and urban incident Parkinson Disease: a community health study of Medicare beneficiaries by using geographic information systems.
- Estimation of particulate mass and manganese exposure levels among welders.
- Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.
- Geographic and ethnic variation in Parkinson Disease: a population-based study of US Medicare beneficiaries.
- Novel THAP1 sequence variants in primary Dystonia.
- Sensitivity and specificity of the finger tapping task for the detection of psychogenic movement disorders.
- Genome-wide association study reveals genetic risk underlying Parkinson's Disease.
- Conjugal Parkinsonism and Parkinson Disease: a case series with environmental risk factor analysis.
- A population-based study of parkinsonism in an Amish community.
- Validity and reliability of an occupational exposure questionnaire for parkinsonism in welders.
- High-throughput mutational analysis of TOR1A in primary Dystonia.
- The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson''s Disease: the GenePD study.
- Prospective study examining remote effects of botulinum toxin a in children with cerebral Palsy.
- LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson''s Disease.
- Huntington CAG repeat size does not modify onset age in familial Parkinson's Disease: the GenePD study.
- Replication of association between ELAVL4 and Parkinson Disease: the GenePD study.
- Haplotypes and gene expression implicate the MAPT region for Parkinson Disease: the GenePD Study.
- Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer''s and Parkinson''s Disease.
- High dose botulinum toxin A for the treatment of lower extremity hypertonicity in children with cerebral Palsy.
- Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient.
- Association of alpha-synuclein gene haplotypes with Parkinson''s Disease.
- Herbicide exposure modifies GSTP1 haplotype association to Parkinson onset age: the GenePD Study.
- The impact of litigation on neurologic research.
- The use of botulinum toxin therapy for lower-extremity spasticity in children with cerebral Palsy.
- Influence of heterozygosity for parkin mutation on onset age in familial Parkinson Disease: the GenePD study.
- Relative risk of spread of symptoms among the focal onset primary Dystonias.
- [18F]FDOPA PET as an endophenotype for Parkinson's Disease linkage studies.
- A rapid method for mass screening for parkinsonism.
- BDNF genetic variants are associated with onset age of familial Parkinson Disease: GenePD Study.
- Prevalence of parkin gene mutations and variations in idiopathic Parkinson''s Disease.
- Absence of previously reported variants in the SCNA (G88C and G209A), NR4A2 (T291D and T245G) and the DJ-1 (T497C) genes in familial Parkinson''s Disease from the Gene...
- Prevalence of parkinsonism and relationship to exposure in a large sample of Alabama welders.
- [18F]FDOPA PET and clinical features in parkinsonism due to manganism.
- Pathophysiology of parkinsonism due to hydrocephalus.
- Novel haplotypes in 17q21 are associated with progressive supranuclear Palsy.
- Levodopa with carbidopa diminishes glycogen concentration, glycogen synthase activity, and insulin-stimulated glucose transport in rat skeletal muscle.
- Association of a variation in the promoter region of the brain-derived neurotrophic factor gene with familial Parkinson''s Disease.
Schools
Northwestern Center Feinberg School of Medicine
Northwestern Meml Hospital
Washington University School Med Barnes Hospital
Procedures Preformed
- EEG (Electroencephalogram)
- Non-Cosmetic Chemodenervation
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Bell's Palsy
- Convulsions
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- Regional Top Doctor
Education
-
Washington University - Barnes-Jewish Hospital -
McGaw Medical Center of Northwestern University -
Northwestern University Feinberg School of Medicine
Hospital
-
Barnes-Jewish Hospital -
St. Louis Children's Hospital
Drug Facts
| NPI NUMBER | 1174549307 | |
| NPPES Provider LastName | RACETTE | |
| NPPES Provider FirstName | BRAD | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Neurology | |
| Total Claim Count | 1347.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174549307 |
| Last Name Of The Provider | RACETTE |
| First Name Of The Provider | BRAD |
| View All |
Similar Doctors
|
Dr. Ksenija Kos, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raman Malhotra, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Stanley Iyadurai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Douglas P. Larsen, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Steven M. Rothman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Abhay Kumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sylvia Awadalla, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joshua H. Buck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leah R. Givens, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charlene J. Ong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Samer D. Tabbal, MD
This Doctor is OpenDoctor Recommended.
|